Therapeutic Research

No data available.
Please log in to see this content.
You have no subscription access to this content.
The full text of this article is not currently available.
Azelnidipine Decreased Plasma Aldosterone andPlasminogen Activator Inhibitor Type 1 Levelsin the Hypertensive Patients with Type 2 Diabetes Mellitus―the Jikei Azelnidipine study in the patients withHypertension and Diabetes Mellitus(JAz-HDM)―
Rent this article for

Full text loading...


Data & Media loading...

This is a required field
Please enter a valid email address

Oops! This section, does not exist...

Use the links on this page to find existing content.

Sign in or Register
Please sign in or register to use this feature
Complete your profile
Please complete your profile to use this feature